Tag: Paul Perreault
Paul McKenzie to take reins as CSL’s new CEO, managing director
Global biotechnology giant CSL Limited has named Paul McKenzie as its chief executive officer and managing director, effective 6 March 2023.
CSL boosts AU’s plasma manufacturing capability with new Fractionation Facility
Global biotech company CSL has opened a new $900 million Plasma Fractionation Facility in Victoria, bolstering the future of plasma manufacturing in Australia.
CSL completes acquisition of novel gene therapy for haemophilia B
CSL Limited has wrapped up the acquisition of uniQure’s etranacogene dezaparvovec, a novel gene therapy for the treatment of haemophilia B.
Under the agreement, CSL...
Featured Article
“New Starts Here”: AGHA launches national platform for gift and homewares
Australia’s peak organisation for the gift and homewares sector, the Australian Gift & Homewares Association (AGHA), has revealed plans for a major expansion in 2026, introducing Gifted Melbourne 2026 to complement the long-established AGHA Sydney Gift Fair.
